CAS: 339186-68-4 - Matuzumab
Fórmula:Unspecified
- Sinónimos:
- Emd 62000
- Emd 7200
- Emd 72000
- Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal 425 γ1-chain), disulfide with human-mouse monoclonal 425 κ-chain, dimer
- Immunoglobulin G1, anti-(human epidermal growth factor receptor) (humanized MAb 425 γ1-chain), disulfide with humanized MAb 425 κ-chain, dimer
- Immunoglobulin G1, anti-(human epidermal growth factor receptor)(humanized MAb 425 gamma-1 chain), disulfide with humanized MAb 425 kappa-chain, dimer
- KGaA
- Matuzumab [INN]
- Merck KGaA
- Matuzumab
- Ver más sinónimos
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Matuzumab REF: TM-T9922CAS: 339186-68-4 | 95% | 212,00 €~1.568,00 € | Mar 14 Ene 25 |
 | Matuzumab - 10 mg/ml REF: 3D-BM165590CAS: 339186-68-4 | Min. 95 Area-% | 1.164,00 €~1.707,00 € | Vie 24 Ene 25 |
Matuzumab
CAS:339186-68-4
Matuzumab (EMD 72000) is a humanized monoclonal antibody targeting EGFR that can be used to …
Pureza:
95%
Forma y color:
Liquid
Peso molecular:
145.9 kDa
Ref: TM-T9922
| 1mg | 212,00 € | ||
| 5mg | 541,00 € | ||
| 10mg | 760,00 € | ||
| 25mg | 1.160,00 € | ||
| 50mg | 1.568,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Matuzumab - 10 mg/ml
CAS:339186-68-4
Intereferes with EGFR homodimerisation; cancer therapy
Pureza:
Min. 95 Area-%
Forma y color:
Powder
Ref: 3D-BM165590
| 1mg | 1.164,00 € | ||
| 2mg | 1.431,00 € |
Entrega estimada en Estados Unidos, el Viernes 24 de Enero de 2025
